213 related articles for article (PubMed ID: 29235475)
21. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members.
Ilaria RL; Van Etten RA
J Biol Chem; 1996 Dec; 271(49):31704-10. PubMed ID: 8940193
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitin-mediated interaction of p210 BCR/ABL with β-catenin supports disease progression in a murine model for chronic myelogenous leukemia.
Chen R; Hu T; Mahon GM; Tala I; Pannucci NL; Ozer HL; Whitehead IP
Blood; 2013 Sep; 122(12):2114-24. PubMed ID: 23950177
[TBL] [Abstract][Full Text] [Related]
23. Differential signaling through p190 and p210 BCR-ABL fusion proteins revealed by interactome and phosphoproteome analysis.
Cutler JA; Tahir R; Sreenivasamurthy SK; Mitchell C; Renuse S; Nirujogi RS; Patil AH; Heydarian M; Wong X; Wu X; Huang TC; Kim MS; Reddy KL; Pandey A
Leukemia; 2017 Jul; 31(7):1513-1524. PubMed ID: 28210003
[TBL] [Abstract][Full Text] [Related]
24. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
[TBL] [Abstract][Full Text] [Related]
25. Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains.
Sha F; Gencer EB; Georgeon S; Koide A; Yasui N; Koide S; Hantschel O
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14924-9. PubMed ID: 23980151
[TBL] [Abstract][Full Text] [Related]
26. Chronic Myelogenous Leukemia with Double Philadelphia Chromosome and Coexpression of p210 and p190 Fusion Transcripts.
Cruz SSD; Seabra AD; Macambira LHR; Carneiro DM; Nunes PF; Pontes TB; Mello-Junior FAR; Leão LBC; Cordeiro FNCDS; Carneiro TX; Moreira-Nunes CA; Burbano RMR
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456386
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of Clinical Outcomes between P190 and P210 Trans-cripts in Adult Ph Chromosome Positive Acute Lymphoblastic Leukemia in the New Era of TKI].
Qiu LL; Lu YJ; Jing Y; Yu L; Liu DH; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):369-74. PubMed ID: 27150994
[TBL] [Abstract][Full Text] [Related]
28. Influence of BCR/ABL fusion proteins on the course of Ph leukemias.
Telegeev GD; Dubrovska AN; Dybkov MV; Maliuta SS
Acta Biochim Pol; 2004; 51(3):845-9. PubMed ID: 15448745
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
Jain SK; Langdon WY; Varticovski L
Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
Serrano J; Roman J; Sanchez J; Jimenez A; Castillejo JA; Herrera C; Gonzalez MG; Reina L; Rodriguez MC; Alvarez MA; Maldonado J; Torres A
Blood; 2000 Apr; 95(8):2659-65. PubMed ID: 10753848
[TBL] [Abstract][Full Text] [Related]
31. SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.
Pendergast AM; Gishizky ML; Havlik MH; Witte ON
Mol Cell Biol; 1993 Mar; 13(3):1728-36. PubMed ID: 8441409
[TBL] [Abstract][Full Text] [Related]
32. RNAi-mediated silencing of p190Bcr-Abl inactivates Stat5 and cooperates with imatinib mesylate and 17-allylamino-17-demetoxygeldanamycin in selective killing of p190Bcr-Abl-expressing leukemia cells.
Futami M; Hatano T; Soda Y; Kobayashi S; Miyagishi M; Tojo A
Leukemia; 2008 Jun; 22(6):1131-8. PubMed ID: 18368071
[TBL] [Abstract][Full Text] [Related]
33. SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl.
Chen J; Yu WM; Daino H; Broxmeyer HE; Druker BJ; Qu CK
Blood; 2007 Jan; 109(2):778-85. PubMed ID: 17003374
[TBL] [Abstract][Full Text] [Related]
34. Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells.
LaMontagne KR; Hannon G; Tonks NK
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14094-9. PubMed ID: 9826659
[TBL] [Abstract][Full Text] [Related]
35. [Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia].
Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Motomura S; Kodama F; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2001 Feb; 42(2):89-93. PubMed ID: 11280922
[TBL] [Abstract][Full Text] [Related]
36. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
Campbell ML; Li W; Arlinghaus RB
Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
[TBL] [Abstract][Full Text] [Related]
37. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
Winter SS; Greene JM; McConnell TS; Willman CL
Leukemia; 1999 Dec; 13(12):2007-11. PubMed ID: 10602422
[TBL] [Abstract][Full Text] [Related]
38. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
[TBL] [Abstract][Full Text] [Related]
39. The SH2 domain of P210BCR/ABL is not required for the transformation of hematopoietic factor-dependent cells.
Ilaria RL; Van Etten RA
Blood; 1995 Nov; 86(10):3897-904. PubMed ID: 7579359
[TBL] [Abstract][Full Text] [Related]
40. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice.
Voncken JW; Kaartinen V; Pattengale PK; Germeraad WT; Groffen J; Heisterkamp N
Blood; 1995 Dec; 86(12):4603-11. PubMed ID: 8541551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
